久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Basic Info

  • Grade: Pharmaceutical Grade

    Factory Location: Changsha,Hunan,China

    Main Sales Markets: North America,Western Europe,Eastern Europe,Asia,Middle East

  • Sample Provided: no

    Payment Terms: L/L

    Remdesivir (GS-5734) is a new antiviral drug in the nucleotide analog category. It is not currently approved globally for any indication. With the deepening of research, it was discovered that the antiviral effect of Remdesivir is not limited to filamentous viruses such as Ebola virus, and it also has inhibitory effects on a variety of viruses such as coronavirus. The U.S. Food and Drug Administration (FDA) reviewed the company's application for an investigational new drug (IND) for Remdesivir to treat Covid-19, and granted investigational new drug authorisation to study the drug in February 2020.

Send your message to this supplier
  • From:
  • To:
    Hunan HuaTeng Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service